UVA scientists develop new approach to machine learning for identifying heart drug

UVA scientists develop new approach to machine learning for identifying heart drug

University of Virginia scientists have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart attack or other injuries. Jeff Saucerman, PhD. Image Credit: University of Virginia The new machine-learning tool has already found a promising candidate to help prevent …

Read more

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

Ghent University and the booming Ghent biotech landscape welcome a brand new spin-off: Amalus Therapeutics is developing a new class of drugs that selectively target corrupt fibroblast cells. This innovative approach offers the potential to greatly improve the prospects of patients with cancer or fibrotic diseases. The Belgian-Danish company is supported financially through BioInnovation Institute’s …

Read more